Health claims substantiation for probiotic and prebiotic products

Gut Microbes

Volumn 2, Issue 3, 2011, Pages 127-133

  Sanders, Mary Ellen ^a   Heimbach, James T ^b   Pot, Bruno ^c   Tancredi, Daniel ^d   Lenoir Wijnkoop, Irene ^e   Lähteenmäki Uutela, Anu ^f   Gueimonde, Miguel ^g   Bañares, Silvia ^h  

^a DAIRY AND FOOD CULTURE TECHNOLOGIES   (United States)

^b JHeimbach LLC   (United States)

^c INSTITUT PASTEUR DE LILLE   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DANONE RESEARCH   (France)

^f UNIVERSITY OF TURKU   (Finland)

^g DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^h Universitat Abat Oliba CEU   (Spain)

Author keywords

Health claims; Homeostasis; ISAPP; Prebiotic; Probiotic; Regulatory; Substantiation

Indexed keywords

BIOLOGICAL MARKER; PREBIOTIC AGENT; PROBIOTIC AGENT;

ARTICLE; ATOPIC DERMATITIS; CLOSTRIDIUM DIFFICILE INFECTION; CONSUMER; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DIET SUPPLEMENTATION; DRUG LEGISLATION; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; FOOD SAFETY; GOVERNMENT REGULATION; HEALTH STATUS; HOMEOSTASIS; HUMAN; INFECTION; MEDICAL RESEARCH; PRACTICE GUIDELINE; RISK REDUCTION; STANDARD; TRAVELLER DIARRHEA; TREATMENT RESPONSE; VIRAL GASTROENTERITIS;

EID: 80051744281     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.2.3.16174     Document Type: Article

References (26)

1. Hofmann B. Simplified models of the relationship between health and disease. Theor Med Bioeth 2005; 26:355-77.
2. Tengland PA. Health promotion and disease prevention: logically different conceptions? Health Care Anal 2010; 18:323-41.
3. Tengland PA. Health promotion or disease prevention: a real difference for public health practice? Health Care Anal 2010; 18:203-21.
4. Sanders ME, Levy DD. The science and regulations of probiotic food and supplement product labeling. Annals New York Acad Sci 2011; 1219:1-23; DOI:10.1111/j.1749-6632.2010.05956.x.
5. Yamada K, Sato-Mito N, Nagata J, Umegaki K. Health claim evidence requirements in Japan. J Nutr 2008; 138:1192-8.
6. Helman CG. Disease versus illness in general practice. J Royal Coll Gen Practitioners 1981; 31:548-52.
7. Stanford Encyclopedia of Philosophy. Concepts of Disease and Health 2008; (Accessed February 24, 2011, at http://plato.stanford.edu/entries/healthdisease/).
8. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101:812-22.
9. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 2010; 11:3048.
10. Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr 2008; 138:1091-5.
11. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 2006; 91:814-9.
12. Merenstein D, Murphy M, Fokar A, Hernandez RK, Park H, Nsouli H, et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. Eur J Clin Nutr 2010; 64:669-77.
13. Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 2009; 124:172-9.
14. Cummings JH, Christie S, Cole TJ. A study of fructo oligosaccharides in the prevention of travellers' diarrhoea. Aliment Pharmacol Ther 2001; 15:1139-45.
15. Lewis S, Burmeister S, Brazier J. Effect of the prebiotic oligofructose on relapse of Clostridium difficileassociated diarrhea: a randomized, controlled study. Clin Gastroenterol Hepatol 2005; 3:442-8.
16. Waligora-Dupriet AJ, Campeotto F, Nicolis I, Bonet A, Soulaines P, Dupont C, et al. Effect of oligofructose supplementation on gut microflora and wellbeing in young children attending a day care centre. Int J Food Microbiol 2007; 113:108-13.
17. Regulation (Ec) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods, Article 6. 2006; (Accessed February 24, 2011, at http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2006:404:0009:0025:EN:PDF).
18. Emord JW. Pearson v. Shalala: The beginning of the end for FDA speech suppression. J Public Policy Marketing 2000; 19:139-43.
19. de Vos WM, Castenmiller JJM, Hamer RJ, Brummer RJM. Nutridynamics-studying the dynamics of food components in products and in the consumer. Curr Opin Biotechnol 2006; 17:217-25.
20. Blumberg J, Heaney RP, Huncharek M, Scholl T, Stampfer M, Vieth R, et al. Evidence-based criteria in the nutritional context. Nutr Rev 2010; 68:478-84.
21. Cox MJ, Huang YJ, Fujimura KE, Liu JT, McKean M, Boushey HA, et al. Lactobacillus casei abundance is associated with profound shifts in the infant gut microbiome. PLoS One 2010; 5:8745.
22. Heird WC. Biochemical homeostasis and body growth are reliable end points in clinical nutrition trials. Proceedings of the Nutrition Society 2005; 64:297-303.
23. Council of Europe. Homeostasis, a model to distinguish between foods (including nutritional supplements) and medicinal products 2008; (Accessed February 24, 2011, at http://www.coe.int/t/e/social_cohesion/soc-sp/homeostasis%20%282%29.pdf).
24. Worldbank. Health Enhancing Foods. Agriculture and Rural Development Discussion Paper 30, 2006; (Accessed March 1, 2011, at http://siteresources.worldbank.org/INTARD/Resources/Health_Enhacing_Foods_ARD_DP_30_final.pdf).
25. Gray MA. Cost-effectiveness analyses alongside randomized clinical trials. Clinical Trials 2006; 3:538-42.
26. Nutrition economics-characterising the economic and health impact of nutrition. Br J Nutr 2010; 27:1-9.